Pfizer asks FDA to approve omicron COVID-19 booster shots for 5- to 11-year-olds

Elementary-aged children already received smaller doses of Pfizer’s original COVID-19 vaccine, a third of the dose given to everyone 12 and older.

FILE - A young girl gets a COVID-19 vaccination in San Jose, Calif., on June 21, 2022. booster shot to children ages 5 to 11.

If the Food and Drug Administration agrees, they would start getting a kid-sized dose of the new omicron-targeted formula when it is time for their booster. Pfizer and its partner BioNTech also announced a new study of the omicron-focused booster in even younger children, those ages 6 months through 4 years, to test different doses.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

fox5ny /  🏆 587. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer CEO Tests Positive for COVID a Second TimeAlbert Bourla, CEO of COVID-19 vaccine maker Pfizer, has tested positive for the coronavirus but is showing no symptoms, he said over the weekend.
Read more »

Pfizer seeks to expand COVID omicron booster to 5- to 11-year-oldsIf the FDA agrees, children would start getting a kid-sized dose of the new omicron-targeted formula.
Read more »

Pfizer Requests Clearance for Children’s Covid-19 BoosterPfizer and BioNTech asked U.S. health regulators to clear use of their updated Covid-19 booster in children 5 years to 11 years, just as retooled shots for people 12 and older roll out.
Read more »

Pfizer Asks FDA to Authorize Omicron Covid Booster Shots for Kids Ages 5 to 11Pfizer’s application to the FDA comes before clinical trial results of the omicron BA.5 booster shots have been published.
Read more »

Pfizer submits application for updated COVID boosters for kids 5-11Both of the shots are bivalent, targeting the original 2019 strain as well as BA.4 and BA.5, which today account for 96% of new COVID-19 infections in the United States.
Read more »

Pfizer seeks to expand omicron COVID booster to 5- to 11-year-oldsPfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11.
Read more »